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Epigenetic modifications in eukaryotic genomes occur primarily in the form of 5-methylcytosine (5mC).
These modifications are heavily involved in transcriptional repression, gene regulation, development
and the progression of diseases including cancer. We report a new single-molecule assay for the
detection of DNA methylation using solid-state nanopores. Methylation is detected by selectively
labeling methylation sites with MBD1 (MBD-1x) proteins, the complex inducing a 3 fold increase in
ionic blockage current relative to unmethylated DNA. Furthermore, the discrimination of methylated
and unmethylated DNA is demonstrated in the presence of only a single bound protein, thereby giving a
resolution of a single methylated CpG dinucleotide. The extent of methylation of a target molecule
could also be coarsely quantified using this novel approach. This nanopore-based methylation sensitive
assay circumvents the need for bisulfite conversion, fluorescent labeling, and PCR and could therefore
prove very useful in studying the role of epigenetics in human disease.
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D

NA methylation is one of the most important and frequently occurring epigenetic modifications in
mammalian cells and plays an essential role in regulating cell growth and proliferation. In humans, the
most common epigenetic modification of DNA involves the addition of a methyl group at the 5-carbon
position of cytosine (5-methylcytosine or 5 mC), which occurs exclusively at symmetric CG sites on the DNA
double helix and are referred to as CpG dinucleotides. Hypermethylation of the promoter sequences of various
genes has generally been associated with transcriptional repression through mechanisms such as the recruitment
of methylated CpG binding proteins (MBDs), histone deacetylation and chromatin remodeling1,2. Furthermore,
aberrant methylation in the promoter sequences of various genes can point to specific pathways disrupted in
almost every tumor type including cancers of the prostate, breast, head and neck, lung and liver, whilst correlating
with disease severity and metastatic potential3–8. In fact, the tumor prevalence of many methylation markers is
considerably higher than that of genetic markers4; one example being the hypermethylation of CpG dinucleotides
in the promoter sequence of the glutathione S-transferase pi (GSTP1) gene and is observed in over 90% of prostate
cancer patients9. Methylation analysis will therefore likely play a pivotal role in the diagnosis and treatment of
such diseases.
Interestingly, cancer-specific methylated DNA from most tumor types is present in biopsy specimens and also
exist at very low concentrations in the form of free-floating DNA shed by apoptotic cancer cells4. Current
genome-wide methylation analysis techniques rely on bisulfite genomic sequencing10 (bisulfite conversion of
DNA, PCR amplification and DNA sequencing) and typically require large sample volumes due to DNA degradation during bisulfite conversion11, can exhibit low amplification efficiency and PCR bias12, and are labor
intensive. Targeted methods involving analysis at specific loci or groups of genes such as methylation specific
PCR (MSP)12, MethyLight13,14 and DNA microarrays15 overcome the need for sequencing but still rely on bisulfite
conversion, amplification and complex probe design. Therefore, a bisulfite free, amplification free method
capable of rapidly and accurately determining the methylation status of panels of genes from minute clinical
sample volumes could be of tremendous clinical value.
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This paper demonstrates a new single molecule assay for determining the methylation status of DNA using solid-state nanopores.
Nanopores use the principle of ionic current spectroscopy to electrically interrogate individual DNA molecules with the sensitivity to
discern subtle structural motifs16,17. Fabrication of these devices typically involves the physical sputtering of a single nanometer sized
aperture in a dielectric membrane using a focused electron beam18,19.
The electrophoretic transport of biomolecules through these nanoscale pores has enabled the study of various biophysical phenomena
at the single molecule level20, with potential applications in DNA
sequencing and medical diagnostics16,21–23. (For reviews of nanopore
research, see refs 24–30) Recently, methylated and unmethylated
DNA has been examined optically in nanofluidic channels using
fluorescently labeled proteins bound to the methylation sites31,32.
Nanopore-based ionic current spectroscopy, however, is ideal for
single molecule epigenetic analysis eliminating the need for optical
measurements. Using nanopore based ionic current spectroscopy,
the differentiation of methylcytosine from cytosine has previously
been demonstrated by passing these individual nucleotides through a
biological nanopore33, requiring an exonuclease based cleaving of the
bases from the original molecule. To date ionic current measurements obtained using a solid-state nanopore, have yet to differentiate
methylated from unmethylated single molecules of DNA34,35.
Herein, we demonstrate the electrical discrimination of unmethylated and methylated DNA using solid-state nanopores. Our
technique does not require bisulfite conversion, sequencing or fluorescent tags but rather relies on the detection of methylated CpG
dinucleotides in DNA by labeling with a 75 amino acid region of
the methyl DNA binding protein MBD1, which includes a his-tagged
single DNA binding domain and will hereafter be referred to as
MBD-1x. The translocation of the methylated DNA - MBD-1x complex through a solid-state nanopore induced approximately a 3-fold
increase in the measured blockage current relative to unmethylated
DNA. The binding of a single MBD-1x protein to a methylated DNA
fragment was sufficient for differentiation with high fidelity, thereby
enabling single CpG dinucleotide sensitivity. Methylation could also
be coarsely quantified based on the number of bound MBD-1x proteins per molecule, characterized by distinct timescales in the event
translocation time histograms. As a result, this amplification- and
fluorescent label-free, single molecule assay could be significantly
useful in the rapid screening of epigenetic biomarkers for the early
detection of diseases such as cancer.

Results
Detection of unlabeled methylated and unmethylated DNA. The
electrophoretic transport of double stranded DNA (dsDNA) through
a solid-state nanopore is illustrated in the schematic of Figure 1a, the
inset showing a transmission electron microscope image of a
,4.2 nm diameter pore. The detection of unmethylated and
methylated dsDNA in the absence of MBD-1x was performed
using a ,4.2 nm pore fabricated in 20 nm-thick SiN membranes
according to methods described previously18,19. Briefly, DNA was
introduced into the cis chamber. A positive voltage was applied to
the trans side resulting in the passage of dsDNA through the
nanopore to the trans side. The target fragment used in these
studies was an 827 bp region of DLX1 (see Supplementary Figure
s1 for sequence information), a homeobox gene associated with
forebrain development37. Aberrant methylation of DLX1 has been
reported in several cancers, including lymphoma38, and brain
tumors39. Furthermore, analysis of publicly available methylation
profiling data40 identified significant hypermethylation of DLX1
promoter in lung adenocarcinomas (see Supplementary Figure s2).
Therefore, methylated DLX1 promoter has potential clinical utility
in cancer diagnosis. This 827 bp DLX1 region contained 36 CpG
dinucleotides, which were methylated in-vitro using the M.Sss1
DNA methyltransferase. The methylation of the dsDNA was
SCIENTIFIC REPORTS | 3 : 1389 | DOI: 10.1038/srep01389

confirmed using the restriction enzyme HhaI (see Supplementary
Figure s3). Methylated DLX1 will hereafter be referred to as
mDLX1 and unmethylated DLX1 will be referred to as uDLX1.
Ionic current traces produced by the electrophoretic transport of
mDLX1 through the nanopore at various voltages are shown in
Figure 1b, each downward current pulse indicative of
the passage of a single mDLX1 molecule though the nanopore. A
magnified view of these events is presented in Figure 1c, the key
parameters of interest being the blockage current, DI, induced by
the passage of the molecule through the pore and the event
duration or translocation time, td. Chemical structures of cytosine
and methylated-cytosine, schematics of CpG dinucleotides in
unmethylatd dsDNA and methylated dsDNA, data traces of
uDLX1 and mDLX1 recorded at 300 mV are presented in Figure 1d.
Figure 1e compares the translocation properties (DI and tduration)
of methylated and unmethylated DLX1 through the nanopore as a
function of applied voltage. Each data point on these plots consists of
over 1167 separately recorded DNA translocation events. Voltagedependent transport of both mDLX1 and uDLX1 were observed; step
increases in the applied voltage resulting in higher electrophoretic
forces on the molecule and therefore shorter translocation times
through the pore41,42. As seen in Figure 1e, the single molecule sensitivity of a solid-state nanopore alone is not sufficient to distinguish
methylated from unmethylated DNA with any statistical significance. This is reiterated by the similar td and DI histograms
(Figure 1f), each distribution containing over 2153 translocation
events recorded at 500 mV. Notably, the time constants for
mDLX1 and uDLX1 obtained by exponential fitting to the translocation time histograms of Figure 1f are within 10% of each other (tM 5
0.124 6 0.006 ms, tU 5 0.135 6 0.006 ms), confirming the inability
to consistently distinguish methylated from unmethylated DNA.
This result is not surprising given the subtle structural and chemical
differences that exist between 5-methylcystosine and cytosine
(Figure 1d). We therefore conclude that these differences along with
reported differences in the nanomechanical properties of methylated
versus unmethylated DNA34, are not sufficient to give rise to
detectable differences in their respective ionic current signatures.
Our results are consistent with previous findings35 and reiterate the
need for a methylation specific label in nanopore based methylation
studies.
Formation of DNA/MBD-1x complex. To specifically label methylated DNA, we used the 75 amino acid methylated DNA binding
domain of the protein MBD1. MBD1 plays an important role in gene
silencing by recruiting AFT7IP, which in turn recruits factors such as
the histone methyltransferase SETDB1 and is essential in histone
deacetylation and transcriptional repression in vertebrates43.
Importantly, MBD1 binds symmetrically to methylated but not
unmethylated CpG dinucleotides with high affinity44 and
specificity43. The 75 amino acid MBD-1x was expressed in E. coli
(see Materials and Methods) and protein purity was verified using
Coomassie stained gels and Western blot analysis (Supplementary
Figure s4). Figure 2a illustrates the crystal structures of typical
B-form dsDNA and the methylated-DNA/MBD complex29,30. Xray diffraction and NMR spectroscopy confirm that the binding
domain of MBD1 occupies ,5–6 bp in the major groove of
the dsDNA helix upon binding to a single methylated CpG
dinucleotide45,46. It is therefore likely that only 21–25 of the 36
methyl-CpG sites in the DLX1 probe used here will serve as
functional binding sites for MBD-1x, as only these regions contain
sufficient spacing between sites to physically accommodate the
protein. The relatively small occlusion area of MBD-1x (5–6 bps)
also makes this protein ideal for nanopore based methylation
analysis. Other MBD family proteins such as MBD2 and MeCP2
are known to protect ,12–14 bp around a single binding site47,
and thus would provide less spatial resolution in nanopore based
2

www.nature.com/scientificreports

Figure 1 | Detection of methylated and unmethylated DNA using a solid-state nanopore. (a) Schematic diagram of a nanopore setup. A focused
electron beam of TEM is used to sculpt a nanopore in a thin (,20 nm) silicon nitride membrane; the nanopore chip is sealed between two fluidic cell
chambers containing conductive electrolyte; a voltage is applied across this setup to induce the translocation of single dsDNA molecules through the pore
as shown. (Inset) TEM image of typical ,4.2 nm diameter nanopore used in DNA measurements (scale bar is 10 nm). (b) Characteristic ionic current
traces obtained from the translocation of mDLX1 (827 bp dsDNA with 36 potential CpG methylation sites). Traces were recorded in 600 mM KCl at pH
8.0 electrolyte at various voltage levels. (c) A typical DNA induced current blockade. Parameters of interest are the open pore current, IO, residual blocking
current, IB, (occurs while a single DNA molecule translocates through the nanopore), blockage current DI 5 IB 2 IO, and translocation time of the
molecule, tduration. (d) Schematic showing (top) the chemical difference between cytosine and methylated cytosine; (middle) unmethylated versus a fully
methylated CpG dinucleotide in dsDNA. Data traces of unmethylated- (bottom-left) and methylated-DLX1 (bottom-right) were recorded at 300 mV,
showing similarity between both data traces. (e) Comparison of mDLX1 and uDLX1 transport. DI and td plots as a function of applied voltage. td and DI
refers to the time constant and the blocking current respectively at each voltage. All points are the value of the fit with standard error. Second order of
polynomial fit to DI and exponential fit to td are also shown in short dash (black fits to uDLX1 and red to mDLX1). Each data are overlaid with over
n 5 1167 separate translocation events recorded per data point. Methylated and unmethylated fragments are indistinguishable. (f). td (top) and
DI (bottom) histograms for mDLX1 versus uDLX1 at 500 mV (n . 2153), showing similarity with td_mDLX1 5 0.124 6 0.006 ms, td_uDLX1 5 0.135 6
0.006 ms, DI_mDLX1 5 2449.5 6 5.4 pA and DI_uDLX1 5 2440.8 6 24.3 pA.

ionic current measurements. A top-view of MBD bound to dsDNA,
derived from the crystal structure of the complex, is shown in
Figure 2b. A cross-sectional diameter of ,5 nm is estimated for
the complex containing a single MBD molecule, significantly larger
than the ,2.2 nm cross-sectional diameter of B-DNA. With
multiple bound MBD proteins, this diameter is estimated at
,7.6 nm as methylated binding sites follow the rotation of the
major groove on dsDNA (Supplementary Figure s5). Gel shift
assays (Figure 2c) were used to optimize binding conditions for
complex formation prior to nanopore measurements. In the presence of uDLX1, no complex formation was observed (lanes 1–3).
In contrast, when mDLX1 was combined with MBD-1x, robust
complex formation is observed (lanes 5–9). Complex formation
increases as MBD-1x concentration is increased. Importantly, this
protein-DNA complex formation occurs at salt concentrations as
high as 600 mM KCl (Supplementary Figure s6), which is necessary for achieving high signal to noise ratios in nanopore detection
experiments. We estimate that a 3051 excess of MBD-1x to mDLX1
SCIENTIFIC REPORTS | 3 : 1389 | DOI: 10.1038/srep01389

is sufficient to saturate the available methylated binding sites on the
target fragment.
Discrimination of mDLX1/MBD-1x complex from unmethylated
DNA. Control experiments with nanopores of diameter of 4.5 nm
and 7 nm, where these sizes are comparable with a single MBD-1x
bound to DNA (5 nm) and multiple MBD-1x bound to DNA
(7.6 nm), showed that mDLX1/MBD-1x complex cannot
translocate through these pores (Supplementary Figure s7 and s8).
Consequently, we utilized pores with larger diameters than the
diameter of mDLX1/MBD-1x complex. The transport of uDLX1 at
1 nM of final concentration and the 1530 mDLX1/MBD-1x complex
at 10 pM through ,12 nm diameter pore at an applied voltage of
600 mV is shown in Figure 2d and characteristic events are shown in
Figure 2e. A lower concentration of mDLX1/MBD-1x complex was
used to explore a lower limit of detection. Notably, the transport of
the complex induced deeper current blockades and longer
translocation times relative to uDLX1. This is best represented in
3
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Figure 2 | Differentiation of unmethylated DNA from mDLX1/MBD-1x complex. (a) Structure of B-form dsDNA (left) and methylated DNA/MBD
complex (right). A single MBD protein binds to the methylated CpG site on the major groove of dsDNA, occupying about 6 bps (PDB ID: 1IG4).
(b) Top-down view: the cross-sectional diameter of the complex with a single bound MBD protein is ,5 nm. Multiple bound proteins along the DNA
major groove increase complex diameter to ,7.6 nm. (c) Gel-shift assay showing the high affinity and specificity of MBD-1x for methylated but not
unmethylated DNA. When increasing amounts of MBD-1x protein were incubated with uDLX1, no DNA-protein complex was formed (lanes 1–3), but
when mDLX1 was included a robust, dose-dependent increase in mDLX1 - MBD-1x complex formation was observed (lanes 5–9) Lane 5 and 9 show 155
and 1530 (mDLX:MBD-1x), respectively. Samples were fractionated on an 8% non-denaturing polyacrylamide gel and visualized using autoradiography.
(d) Nanopore ionic current traces recorded in 600 mM KCl, pH 8.0 at 600 mV; uDLX1 events (left), mDLX1/MBD-1x events (right). (e) Characteristic
translocation signatures for uDLX1 (bottom) versus the complex (top) through a ,12 nm pore. Scale bar is 10 nm in the TEM image. Qualitatively, the
mDLX1/MBD-1x complex induces longer, deeper current blockades relative to uDLX1. (f) tduration (left) and DI (right) histograms at 600 mV for uDLX1
(shown in blue 2 n 5 857) and mDLX1 (shown in red 2 n 5 197). Unmethylated DNA and the complex are clearly distinguishable. Exponential fits give
time constants of td_uDLX1 5 0.103 6 0.005 ms and td_mDLX1 5 1.43 6 0.03 ms respectively.

the td histogram and DI all-points histograms of Figure 2f consisting
of n 5 857 unmethylated, and n 5 197 methylated events. Event flux
(number of events per second) was expectedly less in the case of the
complex versus uDLX1 as the entropic barrier associated with
transport of the complex through the pore is significantly higher
relative to uDLX1, in addition to more steric hindrance encountered by the complex during translocation. Fitting exponentials to
the td histogram gave time constants of tM 5 1.43 6 0.03 ms, tU 5
0.103 6 0.005 ms for mDLX1 and uDLX1 respectively, revealing the
ability to statistically differentiate these populations. It should be
noted that the DNA-protein interactions can be reversible as the
KD can be from 106 to 870 nM44. This can indeed result in a wider
distribution of the translocation duration due to varying number of
bound protein on each DNA. However, we also note that the
mDLX1/MBD-1x was clearly distinguishable from the uDLX1
since the translocation durations were different by over an order of
magnitude. Furthermore, an all-point DI histogram provided a
detailed view of the translocation of mDLX1/MBD-1x
translocation through the nanopore. The DI histogram for the
mDLX1/MBD-1x complex shows both a deep current blockade
level and a shallower blockade level consistent with free DNA in
the absence of protein. This demonstrates that the nanopore can
indeed coarsely detect protein-bound regions as well as proteinfree region on a single molecule, thereby enabling methylation
mapping (Supplementary Figure s9). To confirm that the deeper
blockade levels observed in the DI histogram were due to the
DNA/protein complex and not due to the presence of unbound
MBD-1x protein, control experiments examining the transport of
the free protein were attempted. No free MBD-1x translocation
SCIENTIFIC REPORTS | 3 : 1389 | DOI: 10.1038/srep01389

events were observed (Supplementary Figure s10), because MBD1x is positively charged in pH 8 electrolyte, thus will not migrate
through the pore under the voltage polarity used in these experiments. Discrimination experiments using a mixture of uDLX1 and
the mDLX1/MBD-1x complex were also carried out (Supplementary
Figure s11), again with significant differences at deeper current
blockage in prolonged translocation were observed in the transport
of complex over shallow short duration blockages of uDLX1. This
data confirms that a nanopore based technique can differentiate
methylated DNA from unmethylated DNA with high confidence
using a methylation specific label.
Methylation quantification. To quantify the extent of DLX1
methylation, various ratios of MBD-1x to mDLX1 were incubated
and then translocated through nanopores of diameter ranging from 9
to 10nm. A pore diameter of 9–10 nm was specifically selected to
allow for slower complex translocation (see supplementary video of
MD simulation). Translocation data for 1530, 155 and 151 ratios of
mDLX1/MBD-1x are shown in Figures 3a, 3b, and 3c respectively.
Each experiment involved translocating uDLX1 as a control
fragment (lower insert), followed by translocation of the DNAprotein complex through the same nanopore. Current signatures
of uDLX1 and mDLX/MBD-1x complex were compared via
histogram of peak blocking current (uDLX1 in black and mDLX1/
MBD-1x complex in red) along with a TEM image of each of the
nanopore used. Figures 3a to 3c also qualitatively show that by
lowering the ratio of protein to DNA, thereby reducing the mean
number of bound proteins per DNA molecule, a measurable
reduction in the translocation time of the complex can be
4
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Figure 3 | Methylation quantification based on number of bound MBD-1x proteins. MBD-1x protein was incubated with methylated DLX1 DNA at
ratios of (a) 1530, (b) 155 and (c) 151. Characteristic current signatures representing the mDLX1/MBD-1x complex (top) and unmethylated DLX1 DNA
(bottom) through 9–10 nm diameter pores are shown. Current signature histogram of unmethylated DLX1 (black) and methylated DLX1-MBD-1x
complex (red). Histogram was generated with peak current signature value of each event. (Inset) Scale bar is 10 nm in TEM images.
(d) Translocation time histograms representing the mDLX1/MBD-1x complex and unmethylated DLX1 (inset). (e) Methylation Detection (left):
Complexes formed with any ratio of MBD-1x can be discriminated from uDLX1 using blockage current alone (,3-fold increase in blockage current
induced by the complex is seen). Methylation Quantification (right): Complexes formed with different ratios of protein can be differentiated based on the
number of bound MBD-1x molecules. Time constants for the complexes are shown by the red circles: J1530 5 4.51 6 0.48 ms, J155 5 1.67 6 0.17 ms and
J151 5 1.01 6 0.09 ms. Corresponding time constants for uDLX1 were in the range of 0.107 – 0.184 ms MBD-1x on complexes were quantified with
extended translocation duration. 151 complex showed ,7-fold prolonged translocation duration, 155 at ,12-fold and 1530 at ,31-fold respectively
than unmethylated DNA.

observed. This is best visualized in the normalized translocation time
histogram in Figure 3d. As can be seen in Figure 3e-left, for all DNA/
protein ratios examined, mDLX1/MBD-1x can be clearly
distinguished from uDLX1 based on blockage amplitude, DI. The
complex remains clearly distinguishable even at the lowest protein/
DNA ratios examined. Fitting a Gaussian function to the peak value
of the blocking current of DI gave current signatures of mDLX1/
MBD-1x and uDLX1 at all ratios. Current signatures of mDLX1/
MBD-1x complex were obtained at DI1530 5 22.01 6 0.5 nA,
DI155 5 23.09 6 0.44 nA and DI151 5 22.65 6 0.37 nA, while
uDLX1 through the same pores showed current signatures of
DIuDLX1_at1530 5 20.76 6 0.19 nA, DIuDLX1_155 5 20.67 6
0.07 nA and DIuDLX1_151 5 20.87 6 0.24 nA. Overall, regardless
of the ratio of MBD-1x to mDLX1, the nanopore can detect and
identify mDLX1/MBD-1x complex from uDLX1 by about a 3-fold
larger current signature.
Given a 151 DNA-protein ratio, the number of bound proteins per
DNA molecule can be calculated using a Poisson limited random
statistical distribution48. According to this model, the probability that
a single DNA molecule will contain one or fewer bound proteins is
,74%. Therefore, the majority of translocation events observed in
Figure 3c can be credited to the binding of one MBD-1x protein per
SCIENTIFIC REPORTS | 3 : 1389 | DOI: 10.1038/srep01389

mDLX1 molecule (free DNA translocation events not included in the
histogram), and overlapping all-points histogram of blocking
currents between uDLX1 and mDLX1/MBD-1x indicates one or
fewer bound protein to the DNA (Supplementary Figure s12).
Furthermore, as rms current noise is identical in the preceding measurements, we conclude that a methylated DNA fragment with a
single bound protein can give a ,305% enhancement in ionic current relative to unmethylated DNA. This confirms that the nanopore
based methylation analysis technique presented here can indeed
detect the presence of a single bound protein on average on methylated DNA with the sensitivity of a single CpG dinucleotide.
Figure 3e-right, shows distinct time scales of t1530 5 4.51 6
0.48 ms, t155 5 1.67 6 0.17 ms and t 151 5 1.01 6 0.09 ms calculated for the 1530, 155 and 151 distributions respectively, based on
an exponential fitting to the histogram in Figure 3d. Using this
method, methylation quantification in the time domain based on
the number of bound proteins is indeed possible. The uDLX1 control, fitted to in range of 0.107 , 0.184 ms, is shown in the inset of
Figure 3d. The distinct time constants pertaining to the complex
likely result from translocation involving interactions with the pore
walls. To understand the nature of these protein-pore interactions,
molecular dynamics (MD) simulations were conducted as shown in
5
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Figure 4. Figures 4a and 4b illustrate the transport of 63 bp dsDNA
with 3 bound MBD proteins through 12 nm and 10 nm diameter
nanopores respectively. Temporal snapshots from the MD trajectory
reveal that the complex interacts minimally with the pore walls during translocation through a larger 12 nm pore. In contrast, interactions between the complex and the pore are observed in smaller
10 nm pores, the center of mass of the complex remaining anchored
in the pore upon completion of the simulation (Figure 4d). As nanopore diameter is reduced further to 9 nm (Figure 4c), the presence of
even a single protein can induce polymer-pore interactions and the
capture of the complex in the pore, resulting in longer blockade
times. The simulation results agree with experimental data in general. Time constants for 1530 mDLX1/MBD-1x complexes through a
,12 nm pore (1.43 6 0.03 ms) were more than a factor of 3 less than
translocation time constants for 1530 complexes through a ,10 nm
pore (4.51 6 0.48 ms), confirming faster translocation through larger
pores. Comparable time constants were measured for 155 complexes
through a 9 nm pore. The detailed view of an experimental data trace
from an individual mDLX1/MBD-1x shows slow translocation of the
complex due to polymer-pore interactions (Supplementary Figure
s13). These interactions are both hydrophobic and electrostatic in
nature. Once a protein or DNA contacts the pore wall, Van der Waals
interactions between the biomolecule and the pore wall slow down
the translocation velocity of biomolecule as reported previously with
single-stranded DNA49. Electrostatic polymer-pore interactions are

also likely and have been reported to slow DNA in systems where the
nanopore surface charge is opposite in polarity to the charge on the
translocating biomolecule42,50. As our experiments were carried out
in pH 8 electrolyte and as the isoelectric points of MBD1x and the
SiN pore are 8.85 and ,4 respectively51,52, we expect electrostatic
interactions between the positively charged protein and the negatively charged nanopore surface. Thus, longer translocation times are
expected as the number of bound proteins per DNA molecule is
increased.

Discussion
This paper presents a new solid-state nanopore-based direct electrical analysis technique for detecting unmethylated and methylated
DNA at the single molecule level. Using MBD-1x as a methylation
specific label, the methylation status of nucleotide sequences corresponding to the promoter of DLX1, a potential epigenetic biomarker
for cancer, could be rapidly determined without the need for bisulfite
conversion, sequencing or fluorescent tags. Notably, the translocation of the mDLX1-protein complex versus uDLX1 induced a ,3
fold signal enhancement in the pore blockage current, enabling the
electrical detection of a single methylated CpG dinucleotide-protein
complex with high fidelity. The number of methylation sites per
molecule could also be coarsely determined using this approach
based on the number of bound MDB-1x proteins, characterized by
distinct timescales in the corresponding translocation time histograms. While further studies are needed to determine the ultimate
spatial resolution of this technique, these findings could find initial
application in low-resolution gene based methylation analysis and
the mapping of methylated CpG islands in the promoter sequences of
various genes, essential to transcriptional repression and gene silencing3. Extending this technique to high resolution epigenetic mapping
will require further improvements to the nanopore architecture.
Nanopores used in these studies were 20 nm-thick in length (equivalent to ,60 bps of dsDNA) and thus multiple bound proteins contributed to the measured ionic current (Supplementary
Figure s9). By reducing pore thickness to below the size of an individual protein, for example by using monolayer thick graphene
nanopores53 (thickness of ,0.34 nm), it may be possible to accurately quantify and spatially map the location of individual MBD-1x
proteins on a target DNA molecule. This should be feasible as the
translocation of DNA-protein complexes through graphene nanopores has already been demonstrated54. Such a technology could
ultimately find application in clinical settings. Cancer-specific
methylated DNA from most tumor types are known to be present
in biopsy specimens and in patient serum at very low concentrations.
A rapid, accurate and amplification free assay to detect these biomarkers from minute sample volumes could prove invaluable in the
early detection of disease, monitoring disease progression and prognosis. With continued development, solid-state nanopores could
meet this unmet technological and clinical need.
Methods

Figure 4 | Molecular Dynamics (MD) simulations of methylated DNA/
MBD complex through a nanopore. Temporal MD snapshots showing
translocation of 63 bp dsDNA with: (a) 3 bound MBD proteins through a
12 nm pore, (b) 3 bound MBD proteins through a 10 nm pore,
(c) 1 bound MBD protein through a 9 nm pore. As pore size is reduced,
hydrophobic interactions between the complex and the pore begin to
dominate and can arrest the transport of the molecule through the pore.
(d) Center of mass of the complex is shown distance vs. time. Smaller pore
sizes can result in the trapping of the complex in the pore.
SCIENTIFIC REPORTS | 3 : 1389 | DOI: 10.1038/srep01389

Nanopore electrical measurements. Single nanopores of various diameters were
sculpted using a JEOL 2010F field emission gun transmission electron microscope in
20 nm thick, low stress SiN membranes with window sizes of 50 3 50 mm2, supported
on a silicon chip. Following pore formation, nanopore chips were cleaned in Piranha
solution (two parts 95% H2SO4 and one part of 30% of H2O2) for 10 min and
thoroughly rinsed with DI H2O. The chip was then sandwiched in a custom acrylic
holder with the nanopore forming the only electrical path for ions between the two
reservoirs. The recording solution for both sides was prepared with desired
concentrations of KCl at pH 8.0 with 10 mM Tris?HCl and 1 mM EDTA. Ag/AgCl
electrodes were immersed in the two reservoirs and an Axopatch 200B was used for
applying potentials and measuring currents at a bandwidth of 10 kHz. Data was
recorded at a sampling frequency of 100 kHz using a Digidata 1440A data acquisition
system. Instrumental control and data analysis was performed using Clampex 10.2.
All nanopore experiments were performed in a dark, double Faraday cage on an
anti-vibration table at room temperature (22 6 2uC).
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DNA Preparation, Purification and Methylation. The 827 bp DNA fragment used
was generated by conventional PCR of human genomic DNA (G304A, Promega,
Madison, WI) and includes a region of the DLX1 gene (Homo sapiens distal-less
homeobox). The region includes a nontranscribed area adjacent to a CpG island, the
59 untranslated region (UTR), the complete first exon, part of the first intron and 36
potential CpG sites. The PCR primer sequences are; forward:
gaccaatccccagtgattatgcaagac, reverse: ctcaatttgcaactatccagccaagg. The PCR product
was purified using Qiaquick PCR purification kit (Qiagen, Inc., Valencia, CA). 50 mg
of DNA was methylated in 10 ml using 500 U CpG Methyltransferase M.SssI, New
England Biolabs (Ipswich, MA) #M0226M, and 160 mM s-adenosyl-methionine
(SAM) according to manufacturer’s instructions. 33 mg of unmethylated control
DNA was treated in the same manner except that no M.SssI was included in the
reaction. Reactions were carried out at 37uC for 4 hours, then fresh SAM was added
again to 160 mM (320 mM total) and incubated for another 4 hours. DNA was
precipitated with ethanol and agarose gel purification was performed using Qiaquick
kit with gel extraction protocol. Efficiency of methylation was shown to be high by
nearly complete protection from Hha1 (a methylation sensitive enzyme) restriction
digestion. There are 4 Hha1 restriction sites in this 827 bp fragment.
MBD-1x protein purification. BL21DE3pLysS E. coli that had been transformed
with a bacterial expression vector encoding his-tagged MBD-1x (Kindly provided by
Dr. Adrian Bird, University of Edinburgh) was exposed to 1 mM IPTG and incubated
on an orbital shaker at 37uC for 3 hours. Bacteria was then chilled on ice, centrifuged
at 5000 3 g for 5 minutes at 4uC and subjected to 3 freeze/thaw cycles. Lysis buffer
(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) was added and the
bacterial lysate was sonicated and spun at 10,000 3 g for 40 minutes at 4uC. The
cleared lysate was added to a column packed with nickel-NTA agarose resin
(Quiagen, Valencia, CA) on an Econo Protein Purification System (BioRad, Hercules,
CA) and incubated for 2 hours to allow the his-tagged protein to bind to the nickel
column. Guanadinium hydrochloride (5.5 M) was added to the column to denature
the protein and a linear guanadinium hydrochloride gradient (5.5–0 M) was used to
refold the protein. This renaturation step was critical for MBD-1x activity. The
refolded MBD-1x was eluted with increasing concentrations of imidazole
(10–250 mM) in elution buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8.0). Protein
purity was assessed with Coomassie-stained gels and Western blot analysis using an
anti-His antibody (SC-803, Santa Cruz Biotechnology, Santa Cruz, CA).
Gel shift assays. The 827 bp uDLX1 and mDLX1 DNA was end labeled with
c[31P]ATP and T4 polynucleotide kinase (New England Biolabs, Ipswich, MA) and
the radiolabeled DNA was separated from free31P using Quick Spin Columns (Roche
Diagnostics Corporation, Indianapolis, IN). The indicated amounts of purified
MBD-1x were added to binding buffer (15 mM Tris pH 7.5, 80 mM KCl, 0.4 mM
dithiothreitol, 0.2 mM EDTA, 1 ug poly[deoxyinosine/deoxycytosine], 10% glycerol)
and incubated for 15 minutes at room temperature. Radiolabeled DNA was added
and incubated for 25 minutes at room temperature in a final volume of 20 ml. Samples
were fractionated on a low-ionic strength polyacrylamide gel at 4uC with buffer
recirculation as previously described55. Bands were visualized using autoradiography.
Molecular dynamics simulation - atomic model. The atomic model of silicon nitride
membrane was constructed as described previously49. The thickness of the membrane
is 20 nm. A symmetric double-conical pore was produced by removing atoms from
the silicon nitride membrane with the diameter of the pore corresponds to
experiment (9 nm, 10 nm and 12 nm). Atomic coordinates of mDNA-MBD
complex were taken from the NMR structure of the methyl binding domain of MBD1
complexed with mDNA (Protein Data Bank entry code 1IG446). Three mDNA-MBD
complex were linked together to generate a long mDNA binding with three MBD
proteins, see Figure 4. The sequence of DNA is: 59-TATCmCGGATACGTATC
CGGTATCmCGGATACGTATCCGGATATATCmCGGATACGTATCCGG
ATA-39. The specific binding sites (mCG) of mDNA are marked in red. The topology
file of DNA and protein along with the missing hydrogen atoms was generated using
the psfgen plug-in of VMD56. mDNA-MBD complex was placed in front of the pore
and was solvated in a water box with 0.6 M KCl added. The final systems include ,1.1
million atoms. Simulations were performed using the program NAMD 2.8 with the
CHARMM27 force field for DNA57, the CHARMM22 force field for proteins with
CMAP corrections58,59 and the TIP3P water model60. Periodic boundary condition
was employed. The integration time step used was 1 fs with particle-mesh Ewald
(PME) full electrostatics with grid density of 1/Å3. Van der Waals energies were
calculated using a 12 Å cutoff. A Langevin thermostat was assumed to maintain
constant temperature at 295 K61. Each system was energy-minimized for 30,000 steps
and then equilibrated for 2 ns under NPT ensemble condition to achieve a constant
volume61,62. Production simulations were carried out by applying an electric field
along the z-direction (perpendicular to the membrane). The applied voltage is 0.6 V
as employed in experiments.
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